Deutsche Bank Ag\ Acer Therapeutics Inc. Transaction History

Deutsche Bank Ag\

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$2.16 - $5.41 $26,784 - $67,084	-12,400 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$1.53 - $4.53 $100 - $298	-66 Reduced 0.53%	12,400 $43,000
Q1 2020 May 14, 2020	SELL	$1.18 - $5.86 $120 - $597	-102 Reduced 0.81%	12,466 $25,000
Q4 2019 Feb 14, 2020	BUY	$2.85 - $4.2 $32,071 - $47,262	11,253 Added 855.74%	12,568 $49,000
Q3 2019 Nov 14, 2019	SELL	$1.95 - $3.93 $4,804 - $9,683	-2,464 Reduced 65.2%	1,315 $4,000
Q2 2019 Aug 14, 2019	SELL	$3.45 - $26.86 $19,237 - $149,771	-5,576 Reduced 59.6%	3,779 $14,000
Q1 2019 May 15, 2019	BUY	$20.4 - $25.15 $174,522 - $215,158	8,555 Added 1069.38%	9,355 $226,000
Q4 2018 Feb 14, 2019	BUY	$16.55 - $30.22 $13,240 - $24,176	800 New	800 $16,000

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.